On Tuesday, July 10th, Hyunmin “Ace” Park successfully defended his thesis, “Synthesis of small molecule therapeutics and ligands utilizing rhodium carbenoid chemistry”. Hyunmin’s thesis committee included his thesis advisor, Dr. Huw Davies, and members Dr. Nathan Jui and Dr. Hyunsuk Shim.
In the Fall, Hyunmin will be moving to South Korea to work for LG Chem.
On Monday, July 16th, Lara Patel successfully defended her thesis, “Changes in state: From phase transitions to nucleation and aggregation”. Lara’s thesis committee included her thesis advisor, Dr. James Kindt, and members Dr. Joel Bowman and Dr. Francesco Evangelista.
During her time at Emory, Lara contributed to the publication of four manuscripts:
1. Patel, L. A.; Kindt J. T., Simulations of NaCl aggregation from solution: Solvent determines topography of free energy landscape. J. Chem. Theory Comput. 2018. (Submitted)
2. Zhang, X.; Patel, L. A.; Beckwith, O.; Schneider, R.; Weeden, C.; Kindt, J. T., Extracting aggregation free energies of mixed clusters from simulations of small systems: Application to ionic surfactant micelles. J. Chem. Theory Comput., 2017, 13 (11), 5195–5206. (DOI: 10.1021/acs.jctc.7b00671)
3. Patel, L. A.; Kindt, J. T., Cluster free energies from simple simulations of small numbers of aggregants: Nucleation of liquid MTBE from vapor and aqueous phases. J. Chem. Theory Comput., 2017, 13 (3), 1023–1033. (DOI: 10.1021/acs.jctc.6b01237)
4. Patel, L. A.; Kindt, J. T., Coarse grained molecular simulations of DPPC vesicle melting. Soft Matter, 2016, 12, 1765-1777. (DOI: 10.1039/C5SM02560E)
On Wednesday, July 18th, Morgan Vaughn successfully defended her thesis, “Enzyme Dynamics Elucidated via Temperature Jump Fluorescence Spectroscopy”. Morgan’s thesis committee included her thesis advisor, Dr. Brian Dyer, and members Dr. Stefan Lutz and Dr. Vincent Conticello.
On Thursday, July 12th, Ban-Seok Jeong successfully defended his thesis, “The Dynamics and Kinetics of Proton Related Biological Processes”. Ban-Seok’s thesis committee included his thesis advisor, Dr. Brian Dyer, and members Dr. James T. Kindt and Dr. Khalid Salaita.
What is GRExit? A silly term for a big decision. Starting in Fall 2019, Emory’s Department of Chemistry is joining the “GRExit” wave by dropping the GRE test from our graduate application process.
The GRE (or “Graduate Record Exam”) administered by the Educational Testing Service has been a factor in graduate school admissions since the 1950s. At Emory, we have long required the test as one piece of a package intended to allow us to gauge how well students might do in our program. We are committed to the practice of whole file review, meaning we review all of the materials a student submits instead of using any one factor to “weed out” students from our applicant pool. In the past, we relied on this practice to mitigate any outsize impact on GRE scores. However, we were still faced with interpreting scores as a piece of the puzzle….and over time, our graduate committee found that it was very hard to look past particularly high or low scores as they reviewed the remainder of a file.
Added to that impression, we had access to data on students who accept our admissions offer and matriculate. We haven’t found the GRE to be a very good indicator for student success in the first year of our program. Our sample size is small compared to the large number of students who take the test, but there is more research out there that we can rely on. For instance, consider the following:
Research has also consistently shown that the GRE introduces bias into the review process, disadvantaging women, minorities, and students from economically disadvantaged backgrounds. Some references of note:
We are very concerned about minimizing bias in our admissions process. Our entire graduate admissions team undergoes training about the role of implicit bias in their day-to-day life (a program that draws heavily on the book Blindspot.) We have also piloted the use of a shared evaluation form to help faculty review applications with the same questions in mind. And we are always considering new ways to minimize bias in our review process. With issues of efficacy, predictive value, and bias in mind, removing the GRE from our process seemed like the right path. It’s a decision we may revisit if new research or testing options make the GRE more useful. But for now, we are confident that “GRExit” is the way to go.
What does this mean for you as an applicant? Simply put, you do not have to take the GRE to apply to the Emory chemistry graduate program. We will still practice whole file review – we look forward to reading your personal statements, seeing your faculty of interest selections, and hearing the perspective of your recommenders. We also love when students submit the optional video statement!
Because we are committed to this path, we will not be accepting test scores in the application even if you want to report them. If we receive scores from some students but not from others, we reintroduce potential biases from this test, particularly as we suspect that students are understandably more likely to submit high scores. We will carefully review all of the information that we do request and feel confident in our ability to make a thorough review of each application without the assistance of GRE scores.
As another tangible benefit, we hope this will lessen the financial burden of the application process. You do not need to pay to send your scores to Emory, to take test prep classes or buy test prep books, or to sit the test itself.
What do you think about GRExit? Does it make you more or less likely to apply to Emory? Are you planning to take the GRE for other applications? Are you happy to skip it?
Please feel free to share your comments and, as always, to contact our program if you have any questions.
Planning to apply? Visit chemistry.emory.edu/apply. Applications open September 1st, 2018 and are due by December 1st, 2018 for entry in Fall 2019.
On Wednesday, April 25th, Noel Xiang’ An Li successfully defended his thesis, “Amyloid-beta strain amplification and their connection to tau in Alzheimer’s Disease”. Noel’s thesis committee included his thesis advisor, Dr. David Lynn, and members Dr. Stefan Lutz, Dr. Vincent Conticello, Dr. Lary Walker (Emory Neurology), and Dr. Yury Chernoff (GA Tech Biological Sciences).
Noel is applying for jobs in the pharmaceutical/biotech industry while wrapping up some experiments in the Lynn Lab.
On Friday, April 13th, Andrew Steele successfully defended his thesis, “Natural Products Enabling Biological Discovery: Promysalin and Baulamycins”. Andrew’s thesis committee included his thesis advisor, Dr. William Wuest, and members Dr. Huw Davies and Dr. Dennis Liotta.
Since moving with the Wuest Group to Emory, Andrew has published two papers, bringing his publication count to five. Andrew will be starting a post-doctoral position at Scripps in Florida where he will be working in the lab of Dr. Ben Shen.
On Wednesday, March 14th, Mooeung Kim successfully defended his thesis, “Mechanistic Study on Multi-Electron Processes in POM Catalysis.” Mooeung’s thesis committee included his thesis advisor, Dr. Craig Hill, and members Dr. Brian Dyer and Dr. Cora MacBeth.
Looking forward, Mooeung is planning to move back to Korea, where he will begin working at SAMSUNG in July.